Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control

New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus AUSTIN, Texas--(BUSINESS WIRE)-- Asuragen, Inc. has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic. Asuragen’s proprietary Armor [...]

March 16th, 2020|News|

GEDmatch Partners with Genomics Firm

SAN DIEGO, CA (December 9, 2019) — GEDmatch, a pioneer in consumer genealogy, today announced that it has joined with forensic genomics firm Verogen, Inc. in a move that allows the company to ensure ongoing privacy protections and enhance the customer experience for users of its website. “I am confi [...]

December 9th, 2019|News|

Akoya Biosciences Raises $50M in Financing

Additional Resources Will Support Continued Commercialization of Akoya’s Spatial Biology Platforms CODEX® and Phenoptics™ Company to present at Piper Jaffray 31st Annual Healthcare Conference Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the completion of a $50 million finan [...]

December 5th, 2019|News|